Product Information
ESOMEPRAZOLE MAG DR 40 MG CAP is a generic product labeled by Lannett Company Inc., priced at $0.1218 per EA under NDC 62175084032. Its NADAC has been published 392 times since Apr 3, 2019.
FDA first approved this application on Sep 1, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Lannett Company Inc.NDC
62175084032
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE PELLETS
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ESOMEPRAZOLE MAGNESIUMApproval Type
Generic (ANDA)
FDA Application
ANDA205563FDA Approved
9/1/2017
TE Code
AB
On Market Since
9/1/2017
Pharmacological Classes
Price Statistics
The NADAC for ESOMEPRAZOLE MAG DR 40 MG CAP has been published 392 times since Apr 3, 2019, and over the history we have for it it has declined 63.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1218 per EA |
|---|---|
| All-time high | $0.3348 (Apr 10, 2019) |
| All-time low | $0.1104 (Nov 20, 2024) |
| 52-week high | $0.1434 |
| 52-week low | $0.1180 |
| Median price | $0.1728 |
| Average price | $0.1907 |
| Largest weekly change | -28.0% (Nov 20, 2024) |
| Weeks tracked | 392 |
| Tracking since | Apr 3, 2019 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lannett Company Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Esomeprazole Magnesium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESOMEPRAZOLE MAG DR 40 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for ESOMEPRAZOLE MAG DR 40 MG CAP, manufactured by Lannett Company Inc., is $0.1218 per EA (NDC 62175084032), effective Sep 30, 2026.
How has the price of ESOMEPRAZOLE MAG DR 40 MG CAP changed over time?
Over the history we have for it, the NADAC for ESOMEPRAZOLE MAG DR 40 MG CAP has declined 63.6%. It has been tracked across 392 weekly CMS publications since Apr 3, 2019.
What are the highest and lowest recorded NADAC prices for ESOMEPRAZOLE MAG DR 40 MG CAP?
Since Apr 3, 2019, the NADAC for ESOMEPRAZOLE MAG DR 40 MG CAP has ranged from a low of $0.1104 (Nov 20, 2024) to a high of $0.3348 (Apr 10, 2019), with a median of $0.1728 per EA.
Are there cheaper alternatives to ESOMEPRAZOLE MAG DR 40 MG CAP?
8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ESOMEPRAZOLE MAG DR 40 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures ESOMEPRAZOLE MAG DR 40 MG CAP?
ESOMEPRAZOLE MAG DR 40 MG CAP (NDC 62175084032) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.